“The primary reason for this transaction is to increase the value we can collectively deliver to hospitals and health systems. We are broadening MedAssets’ revenue cycle management solution suite with the addition of Accuro’s ASP-based products,” says John A. Bardis, chairman, president and CEO of MedAssets, in a statement.
MedAssets predicts the combination will result in the ability to deliver near-term financial ROI with minimal or no capital expenditure to the customer and additional opportunity to grow market share by leveraging MedAssets’ national sales organization and leadership position.
